This website uses cookies to ensure that we give you the best experience on our website. Click here for more information.

ok
XGEVA (denosumab)

Terms of Use

The information contained in this site is for healthcare professionals only.

I am not a healthcare professional I confirm to be a healthcare professional

XGEVA® REFERENCES

REFERENCES ON XGEVA® (DENOSUMAB) FOR THE PREVENTION OF SREs IN ADULTS WITH BONE METASTASES FROM SOLID TUMOURS


For more information about XGEVA® (denosumab):

XGEVA® (DENOSUMAB) pharmacovigilance

To ensure safety and monitoring of adverse reactions, a risk management plan has been developed for XGEVA®. Healthcare professionals are encouraged to report XGEVA® side effects.[CHMP AR, p. 85]